Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 15.05
-0.04 (-0.27%)
Apr 21, 2026, 3:00 PM CST
SHA:688526 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 416.94 | 382.35 | 395.93 | 409.52 | 570.74 |
Depreciation & Amortization | 113.25 | 109.5 | 114.27 | 97.69 | 62.64 |
Other Amortization | 0.48 | 0.33 | 0.23 | - | - |
Loss (Gain) From Sale of Assets | 6.9 | 0.33 | 0.09 | - | - |
Asset Writedown & Restructuring Costs | -20.13 | 3.31 | 1.72 | -1.29 | 1.57 |
Loss (Gain) From Sale of Investments | -7.41 | -37.6 | -9.34 | -6.65 | -5.13 |
Provision & Write-off of Bad Debts | - | 11.88 | 84.47 | 23.49 | 7.85 |
Other Operating Activities | -54.19 | -33.46 | -36.09 | -41.45 | -52.19 |
Change in Accounts Receivable | 54.55 | -20.4 | -19.85 | -134.36 | -118.72 |
Change in Inventory | -30.95 | 6.43 | 8.81 | -67.96 | -38.5 |
Change in Accounts Payable | -16.27 | -34.07 | 15.15 | 121.36 | 77.77 |
Change in Other Net Operating Assets | 4.83 | - | - | 6.74 | 9.07 |
Operating Cash Flow | 468.54 | 392.68 | 538.03 | 423.71 | 531.27 |
Operating Cash Flow Growth | 19.32% | -27.02% | 26.98% | -20.25% | 32.77% |
Capital Expenditures | -123.88 | -106.94 | -104.5 | -102.85 | -374.45 |
Sale of Property, Plant & Equipment | 7.75 | 2.59 | 0.18 | 0.08 | - |
Cash Acquisitions | -4.5 | - | -4.05 | -8.46 | - |
Investment in Securities | -606.79 | 161.16 | -281.45 | -582.14 | 12 |
Other Investing Activities | 78.52 | 39.78 | 60.83 | 56.24 | 31.35 |
Investing Cash Flow | -648.89 | 96.59 | -329 | -637.13 | -331.1 |
Long-Term Debt Issued | - | 97 | 236.5 | 271.5 | 78 |
Total Debt Issued | - | 97 | 236.5 | 271.5 | 78 |
Long-Term Debt Repaid | - | -385.09 | -222.84 | -78.84 | -60.01 |
Net Debt Issued (Repaid) | - | -288.09 | 13.66 | 192.66 | 17.99 |
Issuance of Common Stock | - | - | - | 14.84 | 1.86 |
Repurchase of Common Stock | - | -35.29 | - | - | - |
Common Dividends Paid | -199.48 | -204.58 | -97.09 | -93.48 | -136.82 |
Other Financing Activities | 15.21 | 24.79 | -19 | -0.5 | -4.22 |
Financing Cash Flow | -184.27 | -503.18 | -102.43 | 113.52 | -121.18 |
Foreign Exchange Rate Adjustments | -2.06 | 0.02 | 0.05 | - | - |
Net Cash Flow | -366.68 | -13.89 | 106.67 | -99.89 | 78.99 |
Free Cash Flow | 344.66 | 285.74 | 433.53 | 320.86 | 156.82 |
Free Cash Flow Growth | 20.62% | -34.09% | 35.12% | 104.60% | -45.65% |
Free Cash Flow Margin | 36.29% | 30.34% | 40.74% | 32.05% | 14.22% |
Free Cash Flow Per Share | 0.74 | 0.61 | 0.93 | 0.69 | 0.34 |
Cash Income Tax Paid | 91.77 | 109.85 | 98.3 | 96.75 | 86.87 |
Levered Free Cash Flow | -443.43 | 438.28 | 38.93 | 134.02 | -1.1 |
Unlevered Free Cash Flow | -443.43 | 441.27 | 44.03 | 137.43 | 0.04 |
Change in Working Capital | 12.7 | -43.96 | -13.26 | -57.58 | -54.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.